Fuan Pharmaceutical (Group)

Fuan Pharmaceutical (Group) is a prominent Chinese pharmaceutical enterprise focused on the integrated production of active pharmaceutical ingredients (APIs) and finished drug products. The company holds a significant market share in the anti-infective segment, particularly in the production of high-end antibiotics such as carbapenems and cephalosporins. Beyond anti-infectives, Fuan has diversified its portfolio into oncology, cardiovascular, and metabolic health, leveraging its large-scale manufacturing capabilities in Chongqing and other provinces. Listed on the Shenzhen Stock Exchange, the company emphasizes quality through rigorous consistency evaluations and international GMP compliance. Fuan continues to grow through strategic acquisitions and a robust pipeline of generic and value-added medicines.